Bedel Financial Consulting’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-5,000
Closed -$159K 972
2021
Q1
$159K Hold
5,000
0.06% 198
2020
Q4
$104K Hold
5,000
0.05% 220
2020
Q3
$78K Hold
5,000
0.04% 241
2020
Q2
$91K Hold
5,000
0.05% 205
2020
Q1
$78K Hold
5,000
0.05% 211
2019
Q4
$150K Hold
5,000
0.09% 165
2019
Q3
$109K Hold
5,000
0.07% 192
2019
Q2
$126K Hold
5,000
0.08% 179
2019
Q1
$124K Hold
5,000
0.08% 173
2018
Q4
$92K Hold
5,000
0.07% 185
2018
Q3
$129K Hold
5,000
0.09% 172
2018
Q2
$116K Buy
+5,000
New +$103K 0.09% 177

Other funds holding BHC

Bedel Financial Consulting's BHC Position: Q2 2021 in Review

Bedel Financial Consulting sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 5,000 shares — an estimated $159K sold.

Bedel Financial Consulting first reported a position in BHC in Q2 2018 and held it in 12 quarters. The position peaked at $159K in Q1 2021. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Bedel Financial Consulting reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Bedel Financial Consulting sold 5,000 Bausch Health shares in Q2 2021, an estimated $159K.
  • Bedel Financial Consulting first reported a position in Bausch Health in Q2 2018 and held it in 12 quarters.
  • Bedel Financial Consulting's Bausch Health position peaked at $159K in Q1 2021.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Bedel Financial Consulting's 13F filing for Q2 2021, filed 3 Aug 2021.